NDC 70121-1642

vasopressin

Vasopressin

vasopressin is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Amneal Pharmaceuticals Llc. The primary component is Vasopressin.

Product ID70121-1642_3f812f48-a8e6-411a-992d-133c9cdcbcf5
NDC70121-1642
Product TypeHuman Prescription Drug
Proprietary Namevasopressin
Generic NameVasopressin
Dosage FormInjection
Route of AdministrationINTRAVENOUS
Marketing Start Date2022-08-11
Marketing CategoryANDA /
Application NumberANDA212944
Labeler NameAmneal Pharmaceuticals LLC
Substance NameVASOPRESSIN
Active Ingredient Strength20 [USP'U]/mL
Pharm ClassesDecreased Diuresis [PE], Vasoconstriction [PE], Vasopressins [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 70121-1642-2

1 VIAL in 1 CARTON (70121-1642-2) > 1 mL in 1 VIAL (70121-1642-1)
Marketing Start Date2022-08-11
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "vasopressin" or generic name "Vasopressin"

NDCBrand NameGeneric Name
0517-1020VasopressinVasopressin
0548-9701VasopressinVasopressin
42367-570VASOPRESSINVASOPRESSIN
43598-085VasopressinVasopressin
51662-1314VASOPRESSINVASOPRESSIN
51662-1607VASOPRESSINVASOPRESSIN
52584-302VASOPRESSINvasopressin
55150-370VASOPRESSINVASOPRESSIN
55150-371VasopressinVasopressin
63323-302VasopressinVASOPRESSIN
70121-1642vasopressinvasopressin
42023-164VasostrictVasopressin
42023-190VasostrictVasopressin
42023-219VasostrictVasopressin
42023-220VasostrictVasopressin
42023-237VasostrictVasopressin

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.